| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 36 |
| 1 | METHOTREXATE SODIUM | 34 |
| 2 | ETANERCEPT | 31 |
| 3 | METHOTREXATE | 27 |
| 4 | AZATHIOPRINE | 22 |
| 5 | LENALIDOMIDE | 22 |
| 6 | INFLIXIMAB | 20 |
| 7 | MYCOPHENOLATE MOFETIL | 20 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 20 |
| 9 | TACROLIMUS | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACONITUM NAPELLUS, ARNICA MONTANA ROOT, ATROPA BELLADONNA, BELLIS PERENNIS, CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA RECUTITA, ECHINACEA, UNSPECIFIED, ECHINACEA PURPUREA, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, CALCIUM SULFIDE, HYPERICUM PERFORATUM, MERCURIUS SOLUBILIS, ACHILLEA MILLEFOLIUM AND COMFREY ROOT | 1 | 0.0227 |
| 1 | 1.1% SODIUM FLUORIDE PRESCRIPTION DENTAL CREAM | 1 | 0.0060 |
| 2 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 3 | BUPROPION HCL ER | 1 | 0.0021 |
| 4 | PREDNISOLONE SODIUM PHOSPHATE | 5 | 0.0020 |
| 5 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 6 | MEPIVACAINE HYDROCHLORIDE | 2 | 0.0017 |
| 7 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 8 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 9 | CEFPROZIL | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 65 |
| 1 | Corticosteroid [EPC] | 62 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 27 |
| 4 | Thalidomide Analog [EPC] | 23 |
| 5 | Proton Pump Inhibitor [EPC] | 22 |
| 6 | Purine Antimetabolite [EPC] | 22 |
| 7 | Kinase Inhibitor [EPC] | 20 |
| 8 | Alkylating Drug [EPC] | 18 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 5 | Antiseptic [EPC] | 2 | 0.0005 |
| 6 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 7 | Radioactive Diagnostic Agent [EPC] | 1 | 0.0003 |
| 8 | Interleukin-17A Antagonist [EPC] | 10 | 0.0003 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |